[go: up one dir, main page]

HK1249041B - Bcl-2族群抑制剂之口服医药剂型 - Google Patents

Bcl-2族群抑制剂之口服医药剂型 Download PDF

Info

Publication number
HK1249041B
HK1249041B HK18108851.1A HK18108851A HK1249041B HK 1249041 B HK1249041 B HK 1249041B HK 18108851 A HK18108851 A HK 18108851A HK 1249041 B HK1249041 B HK 1249041B
Authority
HK
Hong Kong
Prior art keywords
cancer
dosage form
active ingredient
weight
pharmaceutically acceptable
Prior art date
Application number
HK18108851.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1249041A1 (zh
Inventor
Claudia Packhaeuser
Norbert Steiger
Bernd Liepold
Drazen Kostelac
Martin Knobloch
Original Assignee
AbbVie Deutschland GmbH & Co. KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AbbVie Deutschland GmbH & Co. KG filed Critical AbbVie Deutschland GmbH & Co. KG
Publication of HK1249041A1 publication Critical patent/HK1249041A1/zh
Publication of HK1249041B publication Critical patent/HK1249041B/zh

Links

HK18108851.1A 2009-06-08 2018-07-09 Bcl-2族群抑制剂之口服医药剂型 HK1249041B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US185130P 2009-06-08

Publications (2)

Publication Number Publication Date
HK1249041A1 HK1249041A1 (zh) 2018-10-26
HK1249041B true HK1249041B (zh) 2020-01-17

Family

ID=

Similar Documents

Publication Publication Date Title
US20240197757A1 (en) Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor
US20100311751A1 (en) Solid dispersions containing an apoptosis-promoting agent
HK1249041B (zh) Bcl-2族群抑制剂之口服医药剂型
HK1249041A1 (zh) Bcl-2族群抑制剂之口服医药剂型
HK1220902B (zh) Bcl-2族群抑制剂之口服医药剂型